Clinical trial
Topical 5% Tranexamic Acid as a Treatment for Postinflammatory Hyperpigmentation Due to Acne Vulgaris
NCT03361345 is registered in ClinicalTrials.gov with Wayne State University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Topical 5% Tranexamic Acid as a Treatment for Postinflammatory Hyperpigmentation Due to Acne Vulgaris
- Lead sponsor
- Wayne State University
- Phase
- Phase 2/3
- Overall status
- Withdrawn
- Start date
- November 1, 2018
- Completion date
- January 9, 2022
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
postinflammatory hyperpigmentation